Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia

Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia

Saved in:
Bibliographic Details
Published in:Leukemia Vol. 23; no. 7; pp. 1342 - 1343
Main Authors: Yánez, L, Bermúdez, A, Richard, C, Bureo, E, Iriondo, A
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 01-07-2009
Nature Publishing Group
Subjects:
5-aza-2'-deoxycytidine
Acute lymphoblastic leukemia
Acute lymphocytic leukemia
Antimetabolites, Antineoplastic - therapeutic use
Azacitidine - analogs & derivatives
Azacitidine - therapeutic use
Cancer Research
Care and treatment
Child
Children
Critical Care Medicine
Female
Genetic aspects
Health aspects
Hematology
Humans
Induction therapy
Intensive
Internal Medicine
letter-to-the-editor
Leukemia
Lymphatic leukemia
Medicine
Medicine & Public Health
Oncology
Physiological aspects
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology
Risk factors
Treatment Outcome
Tumor suppressor genes
Spain
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0887-6924
1476-5551
DOI:10.1038/leu.2009.58